FORM DEF 14A

Company

ENDRA Life Sciences Inc.

Filed

September 16, 2024

Period of Report

September 6, 2024

Accession Number

0001654954-24-011972

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →